499 related articles for article (PubMed ID: 24996204)
1. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
Butterfield DA
Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
[TBL] [Abstract][Full Text] [Related]
3. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.
Sultana R; Butterfield DA
J Bioenerg Biomembr; 2009 Oct; 41(5):441-6. PubMed ID: 19777328
[TBL] [Abstract][Full Text] [Related]
4. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
Sultana R; Perluigi M; Butterfield DA
Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
[TBL] [Abstract][Full Text] [Related]
5. Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
Butterfield DA; Boyd-Kimball D
J Alzheimers Dis; 2018; 62(3):1345-1367. PubMed ID: 29562527
[TBL] [Abstract][Full Text] [Related]
6. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
[TBL] [Abstract][Full Text] [Related]
7. Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.
Butterfield DA; Boyd-Kimball D
J Neurochem; 2019 Nov; 151(4):459-487. PubMed ID: 30216447
[TBL] [Abstract][Full Text] [Related]
8. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
Butterfield DA; Castegna A; Lauderback CM; Drake J
Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
[TBL] [Abstract][Full Text] [Related]
9. Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.
Butterfield DA; Swomley AM; Sultana R
Antioxid Redox Signal; 2013 Sep; 19(8):823-35. PubMed ID: 23249141
[TBL] [Abstract][Full Text] [Related]
10. Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapy.
Keeney JT; Miriyala S; Noel T; Moscow JA; St Clair DK; Butterfield DA
Cancer Lett; 2015 Oct; 367(2):157-61. PubMed ID: 26225838
[TBL] [Abstract][Full Text] [Related]
11. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
12. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
Butterfield DA; Kanski J
Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on Oxidative Stress in Alzheimer's Disease and Predictions of Future Research Emphases.
Butterfield DA
J Alzheimers Dis; 2018; 64(s1):S469-S479. PubMed ID: 29504538
[TBL] [Abstract][Full Text] [Related]
14. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
Butterfield DA; Reed T; Newman SF; Sultana R
Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
[TBL] [Abstract][Full Text] [Related]
15. Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories.
Butterfield DA
Ageing Res Rev; 2020 Dec; 64():101049. PubMed ID: 32205035
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics.
Swomley AM; Butterfield DA
Arch Toxicol; 2015 Oct; 89(10):1669-80. PubMed ID: 26126631
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.
Rummel NG; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Cell Mol Life Sci; 2021 Oct; 78(19-20):6533-6540. PubMed ID: 34424346
[TBL] [Abstract][Full Text] [Related]
18. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder.
Butterfield DA; Sultana R
J Alzheimers Dis; 2007 Aug; 12(1):61-72. PubMed ID: 17851195
[TBL] [Abstract][Full Text] [Related]
19. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of Walnuts on Cognition and Brain Health.
Chauhan A; Chauhan V
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
